Saturday 17 October 2026
Export BTMD’s income statement to Excel — free account
biote Corp.
BTMD Healthcare Medical Care Facilities
biote Corp.’s revenue for fiscal 2025 (year ended December 2025) was $192.2 million, down 2.52% from fiscal 2024. In the quarter to June 2026, revenue fell 9.48%, EPS fell 330.0%, free cash flow fell 174.2% and total debt rose 16.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.09
0.02
−1.80%
Follow BTMD
| Dec '17 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 7 | 6 | 7 |
P/E ratio |
— | — | 0.00 | 0.26 | 0.00 | 29.43 | 3.02 |
Altman Z-Score |
— | — | 6.32 | 0.12 | 2.71 | 2.05 | 2.65 |
P/S ratio |
— | — | 0.00 | 0.18 | 0.66 | 1.07 | 0.42 |
P/FCF ratio |
— | — | 2.58 | 0.00 | 5.03 | 5.53 | 2.87 |
Altman Z″-Score (non-manufacturers) |
— | — | 8.21 | (0.47) | 4.65 | (0.52) | 0.97 |
P/Operating CF |
— | — | 7.64 | 4.81 | 17.48 | 17.12 | 10.75 |
Beneish M-Score |
— | — | — | (2.25) | (2.61) | (3.81) | (2.72) |
P/B ratio |
— | — | 18.68 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
— | — | 18.68 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | — | 0.00 | 0.41 | 0.78 | 1.42 | 0.85 |
EV/EBITDA |
— | — | 2.46 | 0.00 | 4.48 | 7.77 | 4.10 |
EV/Operating CF |
— | — | 2.59 | (7.45) | 5.41 | 6.19 | 4.67 |
EV/FCF |
— | — | 2.92 | (6.20) | 6.02 | 7.31 | 5.80 |
Quick Ratio |
— | 0.01 | 1.85 | 4.59 | 4.31 | 0.91 | 0.69 |
Current Ratio |
— | 0.01 | 2.72 | 5.39 | 5.51 | 1.32 | 1.22 |
Net Debt/EBITDA |
— | 0.00 | 0.28 | (0.67) | 0.74 | 1.89 | 2.07 |
Debt/Assets |
0.00% | 0.00% | 68.03% | 105.99% | 72.69% | 87.81% | 99.46% |
Debt/Equity |
— | 0.00 | 8.96 | (2.03) | (3.09) | (1.05) | (2.12) |
Asset Turnover |
— | 0.00 | 5.12 | 1.99 | 1.39 | 1.42 | 1.67 |
Operating CF/Net income |
— | 0.00 | 1.03 | 9.45 | 8.11 | 14.33 | 1.30 |
Capex/Depreciation |
— | — | (2.35) | (0.66) | (0.72) | (1.58) | (1.52) |
Interest Coverage |
— | — | 20.66 | (15.00) | 4.50 | 2.87 | 3.24 |
| — | 0.00% | 1,572.00% | 3.58% | (6.99%) | (4.55%) | (35.45%) | |
| — | 0.00% | 119.75% | (1.17%) | 2.48% | 2.27% | 23.52% | |
ROIC |
— | 0.00% | 150.82% | 0.00% | 0.00% | 0.00% | 68.34% |
Return on Tangible Assets |
— | 0.00% | 101.59% | (1.15%) | 3.27% | 13.39% | 132.37% |
Average Days of Receivables |
— | — | 13.70 | 15.37 | 13.41 | 14.13 | 13.04 |
Research and Development Expense of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | — | 38.71% | 103.73% | 53.32% | 54.49% | 52.97% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.09 | 0.09 |
Share Based Compensation of Revenue |
— | — | 0.00% | 49.82% | 4.89% | 4.43% | 4.64% |
Graham Net Nets |
— | — | (0.04) | (2.36) | (0.57) | (0.74) | (1.27) |
Graham Number |
— | — | 0.00 | 0.00 | 2.26 | 0.00 | 0.00 |
Earnings Yield |
— | — | (1.40%) | 378.39% | (3.38%) | 3.40% | 33.08% |
Free Cash Flow Yield |
— | — | 38.83% | (37.79%) | 19.88% | 18.08% | 34.83% |
Revenue per Share |
— | 0.00 | 18.40 | 20.47 | 7.21 | 5.75 | 6.14 |
Operating CF per Share |
— | 0.00 | 4.45 | (1.14) | 1.05 | 1.32 | 1.13 |
Capex per Share |
— | 0.00 | (0.50) | (0.23) | (0.11) | (0.20) | (0.22) |
Free Cash Flow per Share |
— | 0.00 | 3.95 | (1.36) | 0.94 | 1.12 | 0.91 |
Cash per Share |
— | 0.00 | 3.53 | 9.83 | 3.46 | 1.15 | 0.77 |
Shareholders Equity per Share |
— | 0.00 | 0.54 | (7.23) | (1.42) | (2.98) | (1.61) |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | 0.54 | (7.23) | (1.42) | (2.98) | (1.61) |
Free Cash Flow |
— | 0.00 | 29.91 | (10.99) | 24.17 | 38.29 | 28.33 |
Working Capital |
— | (0.12) | 29.77 | 82.41 | 100.13 | 16.61 | 9.68 |
Capital Expenditures |
— | — | (3.81) | (1.84) | (2.71) | (6.96) | (6.86) |
Net Current Asset Value |
— | (0.12) | (3.12) | (68.74) | (69.50) | (156.44) | (103.34) |
EV/EBIT |
— | — | 2.52 | 0.00 | 5.08 | 8.85 | 4.62 |
Capex to Sales |
— | — | 0.03 | 0.01 | 0.01 | 0.04 | 0.04 |
Price to Operating Income |
— | — | 2.23 | 0.00 | 4.24 | 6.70 | 2.29 |
| Other line items | |||||||
Depreciation/Fixed assets |
— | — | 0.69 | 1.85 | 3.11 | 0.63 | 0.42 |
Cash ROIC |
— | 0.00% | 44.08% | (7.89%) | 14.62% | 85.86% | 35.08% |
Accounts Receivable Turnover |
— | — | 0.00 | 27.09 | 26.95 | 27.31 | 26.51 |
Accounts Payable Turnover |
— | — | 0.00 | 12.90 | 14.00 | 11.66 | 8.68 |
Inventory Turnover |
— | — | 0.00 | 5.25 | 4.06 | 3.62 | 3.24 |
Average Days of Payables |
— | — | 32.52 | 27.50 | 26.20 | 36.50 | 45.42 |
Days of Inventory on Hand |
— | — | 71.89 | 74.79 | 109.15 | 93.21 | 126.84 |
Average Receivables |
— | — | — | 6.09 | 6.88 | 7.22 | 7.25 |
Average Payables |
— | — | — | 4.23 | 4.13 | 4.98 | 6.32 |
Average Inventory |
— | — | — | 10.40 | 14.25 | 16.08 | 16.95 |
Average Assets |
— | 0.07 | 27.24 | 82.99 | 133.47 | 138.83 | 114.99 |
Average Common Equity |
— | (11.30) | 2.08 | (27.07) | (47.41) | (69.37) | (76.30) |
Columns are period end dates